ES8708229A1 - Un procedimiento para la obtencion de 1,3-dihidro-2h-imidazo (4,5-b)-quinolin-2-onas. - Google Patents

Un procedimiento para la obtencion de 1,3-dihidro-2h-imidazo (4,5-b)-quinolin-2-onas.

Info

Publication number: ES8708229A1
Authority: ES; Spain
Prior art keywords: quinolin; imidazo; dihydro; onas; procedure
Prior art date: 1985-04-25
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired

Application number

ES554336A

Other languages

English (en)

Spanish (es)

Other versions

ES554336A0 (es

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Bristol Myers Co

Original Assignee

Bristol Myers Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1985-04-25

Filing date

1986-04-24

Publication date

1987-10-01

1986-04-24 Application filed by Bristol Myers Co filed Critical Bristol Myers Co

1987-10-01 Publication of ES8708229A1 publication Critical patent/ES8708229A1/es

1987-10-01 Publication of ES554336A0 publication Critical patent/ES554336A0/es

Status Expired legal-status Critical Current

Links

125000000217 alkyl group Chemical group 0.000 abstract 4
125000003545 alkoxy group Chemical group 0.000 abstract 3
229910052736 halogen Inorganic materials 0.000 abstract 3
150000002367 halogens Chemical group 0.000 abstract 3
229910052739 hydrogen Inorganic materials 0.000 abstract 3
239000001257 hydrogen Substances 0.000 abstract 3
150000002431 hydrogen Chemical group 0.000 abstract 2
BINWKEIURMBREF-UHFFFAOYSA-N 1,3-dihydroimidazo[4,5-b]quinolin-2-one Chemical class C1=CC=C2N=C(NC(=O)N3)C3=CC2=C1 BINWKEIURMBREF-UHFFFAOYSA-N 0.000 abstract 1
210000001772 blood platelet Anatomy 0.000 abstract 1
239000000496 cardiotonic agent Substances 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
239000003112 inhibitor Substances 0.000 abstract 1
208000010110 spontaneous platelet aggregation Diseases 0.000 abstract 1
125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Hospice & Palliative Care (AREA)
Diabetes (AREA)
Hematology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

ES554336A 1985-04-25 1986-04-24 Un procedimiento para la obtencion de 1,3-dihidro-2h-imidazo (4,5-b)-quinolin-2-onas. Expired ES8708229A1 (es)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US72686985A	1985-04-25	1985-04-25
US06/832,212 US4668686A (en)	1985-04-25	1986-02-26	Imidazoquinoline antithrombrogenic cardiotonic agents

Publications (2)

Publication Number	Publication Date
ES8708229A1 true ES8708229A1 (es)	1987-10-01
ES554336A0 ES554336A0 (es)	1987-10-01

Family

ID=27111398

Family Applications (3)

Application Number	Title	Priority Date	Filing Date
ES554336A Expired ES8708229A1 (es)	1985-04-25	1986-04-24	Un procedimiento para la obtencion de 1,3-dihidro-2h-imidazo (4,5-b)-quinolin-2-onas.
ES557552A Expired ES8802521A1 (es)	1985-04-25	1987-05-14	Un procedimiento para la obtencion de 1,3-dihidro-2h-imidazo (4,5-b)-quinolin-2-onas
ES557551A Expired ES8801829A1 (es)	1985-04-25	1987-05-14	Un procedimiento para la obtencion de 1,3-dihidro-2h-imidazo (4,5-b)-quinolin-2-onas

Family Applications After (2)

Application Number	Title	Priority Date	Filing Date
ES557552A Expired ES8802521A1 (es)	1985-04-25	1987-05-14	Un procedimiento para la obtencion de 1,3-dihidro-2h-imidazo (4,5-b)-quinolin-2-onas
ES557551A Expired ES8801829A1 (es)	1985-04-25	1987-05-14	Un procedimiento para la obtencion de 1,3-dihidro-2h-imidazo (4,5-b)-quinolin-2-onas

Country Status (32)

Country	Link
US (1)	US4668686A (2)
KR (1)	KR940000828B1 (2)
CN (1)	CN1016175B (2)
AT (1)	AT390257B (2)
AU (1)	AU592983B2 (2)
BE (1)	BE904671A (2)
CA (1)	CA1298836C (2)
CH (1)	CH675722A5 (2)
CY (1)	CY1641A (2)
DE (1)	DE3614132A1 (2)
DK (3)	DK164868C (2)
EG (1)	EG18104A (2)
ES (3)	ES8708229A1 (2)
FI (1)	FI83316C (2)
FR (1)	FR2581065B1 (2)
GB (1)	GB2174987B (2)
GR (1)	GR861086B (2)
HK (1)	HK64492A (2)
HU (1)	HU195813B (2)
IL (1)	IL78581A0 (2)
IT (1)	IT1215651B (2)
LU (1)	LU86406A1 (2)
MY (1)	MY102086A (2)
NL (1)	NL8601053A (2)
NO (1)	NO163406C (2)
NZ (1)	NZ215885A (2)
OA (1)	OA08242A (2)
PT (1)	PT82460B (2)
SE (1)	SE461468B (2)
SG (1)	SG29092G (2)
SU (3)	SU1450746A3 (2)
YU (1)	YU46054B (2)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4775674A (en) *	1986-05-23	1988-10-04	Bristol-Myers Company	Imidazoquinolinylether derivatives useful as phosphodiesterase and blood aggregation inhibitors
US4701459A (en) *	1986-07-08	1987-10-20	Bristol-Myers Company	7-amino-1,3-dihydro-2H-imidazo[4,5-b]quinolin 2-ones and method for inhibiting phosphodiesterase and blood platelet aggregation
US4803210A (en) *	1987-05-29	1989-02-07	Merrell Dow Pharmaceuticals Inc.	Cardiotonic tricyclic oxazolones
US4743607A (en) *	1987-05-29	1988-05-10	Merrell Dow Pharmaceuticals Inc.	Cardiotonic tricyclic imidazolones
US4943573A (en) *	1989-11-01	1990-07-24	Bristol-Myers Squibb Company	Imidazo[4,5-b]quinolinyloxyalkanoic acid amides with enhanced water solubility
DE4035854C2 (de) *	1990-11-10	1996-10-02	Daimler Benz Ag	Vorrichtung zum Fangen und Ableiten des von einem Fahrzeugrad hochgeschleuderten Spritzwassers
PH31245A (en) *	1991-10-30	1998-06-18	Janssen Pharmaceutica Nv	1,3-Dihydro-2H-imidazoÄ4,5-BÜ-quinolin-2-one derivatives.
US5158958A (en) *	1992-04-03	1992-10-27	Bristol-Myers Squibb Company	Imidazo[4,5-b]quinolinyl oxy alkyl sulfonyl piperidine derivatives
US5196428A (en) *	1992-04-03	1993-03-23	Bristol-Myers Squibb Company	Imidazo[4,5-b]qinolinyl oxy alkyl ureas
US5348960A (en) *	1992-04-03	1994-09-20	Bristol-Myers Squibb Company	Imidazo[4,5-b]quinolinyl oxy alkyl tetrazolyl piperidine derivatives
US5552267A (en) *	1992-04-03	1996-09-03	The Trustees Of Columbia University In The City Of New York	Solution for prolonged organ preservation
US5208237A (en) *	1992-04-03	1993-05-04	Bristol-Meyers Squibb Company	7-oxypropylsulfonamido-imidazo[4,5-b]quinolin-2-ones
TW593317B (en) *	1993-06-21	2004-06-21	Janssen Pharmaceutica Nv	Positive cardiac inotropic and lusitropic pyrroloquinolinone derivatives
RU2131876C1 (ru) *	1993-07-06	1999-06-20	Пфайзер Инк.	Бициклические тетрагидропиразолпиридины или их фармацевтически приемлемые соли, фармацевтическая композиция, способ ингибирования фосфодиэстеразы, способ лечения
TW530047B (en) *	1994-06-08	2003-05-01	Pfizer	Corticotropin releasing factor antagonists
US6664264B2 (en) *	2000-12-08	2003-12-16	3M Innovative Properties Company	Thioether substituted imidazoquinolines
BRPI0413558A (pt)	2003-08-12	2006-10-17	3M Innovative Properties Co	compostos contendo imidazo substituìdo por hidroxilamina
MXPA06002199A (es)	2003-08-27	2006-05-22	3M Innovative Properties Co	Imidazoquinolinas sustituidas con grupos ariloxi o arilalquilenoxi.
CA2537763A1 (en)	2003-09-05	2005-03-17	3M Innovative Properties Company	Treatment for cd5+ b cell lymphoma
CA2540541C (en) *	2003-10-03	2012-03-27	3M Innovative Properties Company	Alkoxy substituted imidazoquinolines
US7544697B2 (en)	2003-10-03	2009-06-09	Coley Pharmaceutical Group, Inc.	Pyrazolopyridines and analogs thereof
WO2005048945A2 (en) *	2003-11-14	2005-06-02	3M Innovative Properties Company	Hydroxylamine substituted imidazo ring compounds
US7897767B2 (en)	2003-11-14	2011-03-01	3M Innovative Properties Company	Oxime substituted imidazoquinolines
WO2005051317A2 (en)	2003-11-25	2005-06-09	3M Innovative Properties Company	Substituted imidazo ring systems and methods
JP2007517035A (ja)	2003-12-29	2007-06-28	スリーエムイノベイティブプロパティズカンパニー	アリールアルケニルおよびアリールアルキニル置換されたイミダゾキノリン
EP1699788A2 (en)	2003-12-30	2006-09-13	3M Innovative Properties Company	Imidazoquinolinyl, imidazopyridinyl and imidazonaphthyridinyl sulfonamides
WO2005094531A2 (en)	2004-03-24	2005-10-13	3M Innovative Properties Company	Amide substituted imidazopyridines, imidazoquinolines, and imidazonaphthyridines
US8017779B2 (en)	2004-06-15	2011-09-13	3M Innovative Properties Company	Nitrogen containing heterocyclyl substituted imidazoquinolines and imidazonaphthyridines
US8026366B2 (en)	2004-06-18	2011-09-27	3M Innovative Properties Company	Aryloxy and arylalkyleneoxy substituted thiazoloquinolines and thiazolonaphthyridines
US7915281B2 (en)	2004-06-18	2011-03-29	3M Innovative Properties Company	Isoxazole, dihydroisoxazole, and oxadiazole substituted imidazo ring compounds and method
US7897609B2 (en)	2004-06-18	2011-03-01	3M Innovative Properties Company	Aryl substituted imidazonaphthyridines
US20080213308A1 (en) *	2004-09-14	2008-09-04	Nicholas Valiante	Imidazoquinoline Compounds
AU2005326708C1 (en)	2004-12-30	2012-08-30	3M Innovative Properties Company	Substituted chiral fused [1,2]imidazo[4,5-c] ring compounds
JP5543068B2 (ja)	2004-12-30	2014-07-09	スリーエムイノベイティブプロパティズカンパニー	キラル縮合［１，２］イミダゾ［４，５−ｃ］環状化合物
WO2006084251A2 (en)	2005-02-04	2006-08-10	Coley Pharmaceutical Group, Inc.	Aqueous gel formulations containing immune reponse modifiers
CA2597587A1 (en)	2005-02-11	2006-08-17	Coley Pharmaceutical Group, Inc.	Oxime and hydroxylamine substituted imidazo[4,5-c] ring compounds and methods
JP2008535832A (ja)	2005-04-01	2008-09-04	コーリーファーマシューティカルグループ，インコーポレイテッド	ピラゾロピリジン−１，４−ジアミン、およびそのアナログ
JP2008538550A (ja)	2005-04-01	2008-10-30	コーリーファーマシューティカルグループ，インコーポレイテッド	ウイルス感染および腫瘍性疾患を処置するためのサイトカイン生合成の調節因子としての１−置換ピラゾロ（３，４−ｃ）環状化合物
US7906506B2 (en)	2006-07-12	2011-03-15	3M Innovative Properties Company	Substituted chiral fused [1,2] imidazo [4,5-c] ring compounds and methods
US8227603B2 (en)	2006-08-01	2012-07-24	Cytokinetics, Inc.	Modulating skeletal muscle
ES2558517T3 (es)	2006-08-02	2016-02-04	Cytokinetics, Inc.	Ciertas entidades químicas, composiciones y métodos que comprenden imidazopirimidinas
US8299248B2 (en)	2006-08-02	2012-10-30	Cytokinetics, Incorporated	Certain 1H-imidazo[4,5-b]pyrazin-2(3H)-ones and 1H-imidazo[4,5-b]pyrazin-2-ols and methods for their use
WO2008121333A1 (en) *	2007-03-30	2008-10-09	Cytokinetics, Incorporated	Certain chemical entities, compositions and methods
KR101951220B1 (ko)	2011-07-13	2019-02-22	싸이토키네틱스, 인코포레이티드	조합 als 치료법
CN120265631A (zh) *	2023-01-13	2025-07-04	上海超阳药业有限公司	喹啉酮化合物和萘啶酮化合物及其用途

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3932407A (en) *	1973-11-19	1976-01-13	Bristol-Myers Company	Optionally substituted 1,2,3,5-tetrahydroimidezo(2,1-b)-quinazolin-2-ones and 6(H)-1,2,3,4-tetrahydropyimido(2,1-b)quinazolin-2-ones

1986
- 1986-02-26 US US06/832,212 patent/US4668686A/en not_active Expired - Fee Related
- 1986-03-26 CA CA000505136A patent/CA1298836C/en not_active Expired - Fee Related
- 1986-04-18 NZ NZ215885A patent/NZ215885A/xx unknown
- 1986-04-21 AU AU56413/86A patent/AU592983B2/en not_active Ceased
- 1986-04-22 IL IL78581A patent/IL78581A0/xx not_active IP Right Cessation
- 1986-04-22 FI FI861684A patent/FI83316C/fi not_active IP Right Cessation
- 1986-04-23 CN CN86102747A patent/CN1016175B/zh not_active Expired
- 1986-04-23 EG EG237/86A patent/EG18104A/xx active
- 1986-04-24 CH CH1679/86A patent/CH675722A5/de not_active IP Right Cessation
- 1986-04-24 GB GB8610037A patent/GB2174987B/en not_active Expired
- 1986-04-24 DK DK190986A patent/DK164868C/da not_active IP Right Cessation
- 1986-04-24 ES ES554336A patent/ES8708229A1/es not_active Expired
- 1986-04-24 GR GR861086A patent/GR861086B/el unknown
- 1986-04-24 NO NO861617A patent/NO163406C/no unknown
- 1986-04-24 PT PT82460A patent/PT82460B/pt not_active IP Right Cessation
- 1986-04-24 NL NL8601053A patent/NL8601053A/xx not_active Application Discontinuation
- 1986-04-24 FR FR868605966A patent/FR2581065B1/fr not_active Expired - Fee Related
- 1986-04-24 IT IT8620206A patent/IT1215651B/it active
- 1986-04-24 LU LU86406A patent/LU86406A1/fr unknown
- 1986-04-24 BE BE0/216585A patent/BE904671A/fr not_active IP Right Cessation
- 1986-04-24 SU SU864027355A patent/SU1450746A3/ru active
- 1986-04-24 SE SE8601907A patent/SE461468B/sv not_active IP Right Cessation
- 1986-04-25 DE DE19863614132 patent/DE3614132A1/de not_active Ceased
- 1986-04-25 OA OA58845A patent/OA08242A/xx unknown
- 1986-04-25 KR KR1019860003204A patent/KR940000828B1/ko not_active Expired - Lifetime
- 1986-04-25 AT AT0112186A patent/AT390257B/de not_active IP Right Cessation
- 1986-04-25 HU HU861723A patent/HU195813B/hu not_active IP Right Cessation
1987
- 1987-02-27 SU SU874202071A patent/SU1470192A3/ru active
- 1987-05-14 ES ES557552A patent/ES8802521A1/es not_active Expired
- 1987-05-14 ES ES557551A patent/ES8801829A1/es not_active Expired
- 1987-06-23 YU YU116787A patent/YU46054B/sh unknown
- 1987-09-25 SU SU874203391A patent/SU1560056A3/ru active
- 1987-09-29 MY MYPI87002266A patent/MY102086A/en unknown
1991
- 1991-04-30 DK DK080291A patent/DK165248C/da not_active IP Right Cessation
- 1991-05-01 DK DK081091A patent/DK165249C/da not_active IP Right Cessation
1992
- 1992-03-10 SG SG290/92A patent/SG29092G/en unknown
- 1992-08-27 HK HK644/92A patent/HK64492A/xx unknown
- 1992-11-06 CY CY1641A patent/CY1641A/en unknown

Also Published As

Publication number	Publication date
ES557552A0 (es)	1988-07-16
SE8601907L (sv)	1986-10-26
DK165248C (da)	1993-03-22
DK81091A (da)	1991-05-01
DK190986D0 (da)	1986-04-24
GR861086B (en)	1986-09-01
CY1641A (en)	1992-11-06
NO163406B (no)	1990-02-12
DK164868B (da)	1992-08-31
FR2581065A1 (fr)	1986-10-31
GB2174987A (en)	1986-11-19
AT390257B (de)	1990-04-10
KR860008177A (ko)	1986-11-12
FI83316C (fi)	1991-06-25
AU592983B2 (en)	1990-02-01
GB2174987B (en)	1989-08-02
ES8801829A1 (es)	1988-02-16
HK64492A (en)	1992-09-04
FI861684L (fi)	1986-10-26
MY102086A (en)	1992-03-31
CH675722A5 (2)	1990-10-31
YU116787A (en)	1988-04-30
SE461468B (sv)	1990-02-19
SG29092G (en)	1992-05-15
NL8601053A (nl)	1986-11-17
CN1016175B (zh)	1992-04-08
FI83316B (fi)	1991-03-15
DK81091D0 (da)	1991-05-01
EG18104A (en)	1992-09-30
ES557551A0 (es)	1988-02-16
DK80291A (da)	1991-04-30
LU86406A1 (fr)	1986-11-05
BE904671A (fr)	1986-10-24
NO163406C (no)	1990-05-23
NO861617L (no)	1986-10-27
KR940000828B1 (ko)	1994-02-02
NZ215885A (en)	1989-04-26
OA08242A (en)	1987-10-30
DK190986A (da)	1986-10-26
HUT42089A (en)	1987-06-29
FI861684A0 (fi)	1986-04-22
CN86102747A (zh)	1987-02-04
PT82460A (en)	1986-05-01
DK165249C (da)	1993-03-22
AU5641386A (en)	1986-10-30
DK164868C (da)	1993-01-11
SU1470192A3 (ru)	1989-03-30
IT8620206A0 (it)	1986-04-24
YU46054B (sh)	1992-12-21
IT1215651B (it)	1990-02-22
PT82460B (pt)	1988-11-30
ATA112186A (de)	1989-09-15
SU1560056A3 (ru)	1990-04-23
CA1298836C (en)	1992-04-14
DK165248B (da)	1992-10-26
FR2581065B1 (fr)	1990-02-02
HU195813B (en)	1988-07-28
SU1450746A3 (ru)	1989-01-07
DK165249B (da)	1992-10-26
DK80291D0 (da)	1991-04-30
SE8601907D0 (sv)	1986-04-24
DE3614132A1 (de)	1986-11-27
US4668686A (en)	1987-05-26
GB8610037D0 (en)	1986-05-29
ES8802521A1 (es)	1988-07-16
ES554336A0 (es)	1987-10-01
IL78581A0 (en)	1986-08-31

Legal Events

Date	Code	Title	Description
1997-05-16	FD1A	Patent lapsed	Effective date: 19970401

Publication	Publication Date	Title
ES8708229A1 (es)	1987-10-01	Un procedimiento para la obtencion de 1,3-dihidro-2h-imidazo (4,5-b)-quinolin-2-onas.
ES509242A0 (es)	1983-03-16	"procedimiento para preparar nuevos compuestos de cefem".
FI850140L (fi)	1985-07-14	Kemiska foereningar.
DE3369315D1 (en)	1987-02-26	Derivatives of 2-amino-3-acylamino-6-benzylamino pyridine with an anti-epileptic activity
FI862757A0 (fi)	1986-06-27	Pyridonkarbonsyraderivat och foerfarande foer framstaellning av dessa.
NZ503912A (en)	2002-09-27	Piperidinylaminomethyl trifluoromethyl cyclic ether compounds and their use as substance P antagonists
PH23448A (en)	1989-08-07	Quinoline compounds
ATE45354T1 (de)	1989-08-15	Chinoloncarbonsaeurederivate.
ES8304567A1 (es)	1983-03-01	"un procedimiento para preparar nuevos derivados de la n-dihidrotiazolil-3-quinolein-carboxamida".
SE8502525D0 (sv)	1985-05-22	1,3-oxazolidine-2-one derivatives and processes for their preparation
ES2046229T3 (es)	1994-02-01	Composicion antiulcerosa.
ATE59844T1 (de)	1991-01-15	Indolcarboxamidderivate, ihre salze, verfahren und zwischenprodukte, anwendung als heilmittel und zusammensetzungen die sie enthalten.
SE7910072L (sv)	1980-06-08	Pyrrolo- eller pyrido(2,1-c)(1,4)tiaziner eller -tiazepiner
DK160271C (da)	1991-07-22	Analogifremgangsmaade til fremstilling af 5-halogenvinyl-uracil-derivater
DE3267238D1 (de)	1985-12-12	Imidazo(1,2-a)quinoline derivatives
ES514235A0 (es)	1983-08-01	"procedimiento para la preparacion de acidos fenilalcohiloxirancarboxilicos".
ATE30323T1 (de)	1987-11-15	5-phenylaethenylbenzimidazole.
ES8307812A1 (es)	1983-08-01	Un procedimiento para la preparacion de nuevos amidin derivados del acido clavulawilo.
DE3362201D1 (en)	1986-03-27	Semicarbazides, their preparation and use
JPS5735592A (en)	1982-02-26	Novel s-triazolo(1,5-a) pyrimidine derivative
ATE36536T1 (de)	1988-09-15	Phosphoroimidate.